• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number 9-ASD-022
Medical Device Problem Code Difficult to Fold, Unfold or Collapse (1254)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/08/2022
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event or Problem Description
It was reported that on (b)(6) 2022, a 22mm amplatzer septal occluder was selected for an implant using a 10f amplatzer torqvue delivery system(itv).Cobra deformation was noted while deploying the occluder.Device was removed from the patient prior to release from the delivery cable.There was no interaction with the cardiac structures during deployment and no angulation or kink noticed in the delivery system it is unknown if there was a replacement device implanted.The patient remain hemodynamically stable throughout the procedure.No patient consequences were reported.
 
Additional Manufacturer Narrative
An event of device deformation was reported.The device was returned to abbott for investigation and met functional specifications when analyzed under non-physiological conditions.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Based on the information received, the cause of the reported event could not be conclusively determined but may have due to the use of a larger delivery system.There is no indication of a product quality issue with regards to manufacture, design, or labeling.Please note per the instructions for use, the recommended size delivery system for a 22mm amplatzer septal occluder is a 9f delivery system.
 
Event or Problem Description
Subsequent to the previously filed report, additional information was received: it was reported that a second 24mm amplatzer septal occluder was used during the procedure.During the procedure, the tip of the device was curving and forming like a cobra.Both devices were removed from the patient prior to release from the delivery cable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Common Device Name
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT MEDICAL REG# 2135147
5050 nathan ln n
plymouth MN 55442
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key15669542
Report Number2135147-2022-01785
Device Sequence Number15040087
Product Code MLV
UDI-Device Identifier05415067019295
UDI-Public05415067019295
Combination Product (Y/N)N
Initial Reporter CountryIN
PMA/510(K) Number
P000039
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2022
Device Explanted Year2022
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 01/16/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number9-ASD-022
Device Catalogue Number9-ASD-022
Device Lot Number8331229
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 10/08/2022
Supplement Date Received by Manufacturer01/13/2023
Initial Report FDA Received Date10/25/2022
Supplement Report FDA Received Date01/16/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/08/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-